Left Ventricular Mass and Volume With Telmisartan , Ramipril , or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])

The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) showed that the angiotensin receptor blocker telmisartan 80 mg was not inferior to the angiotensin-converting enzyme inhibitor ramipril 10 mg, and the combination no more effective than ramipril alone, in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2009-12, Vol.104 (11), p.1484-1489
Hauptverfasser: Cowan, Brett R., BE, MBChB, Young, Alistair A., PhD, Anderson, Craig, MBBS, PhD, Doughty, Robert N., MD, Krittayaphong, Rungroj, MD, Lonn, Eva, MD, MSc, Marwick, Thomas H., MBBS, PhD, Reid, Chris M., BA, DipEd, MSc, PhD, Sanderson, John E., MD, Schmieder, Roland E., MD, Teo, Koon, MB, PhD, Wadham, Angela K., BA, Worthley, Stephen G., MBBS, PhD, Yu, Cheuk-Man, MD, Yusuf, Salim, MD, Jennings, Garry L., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!